ROSANO, GIUSEPPE MASSIMO CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.227
AS - Asia 1.117
EU - Europa 322
SA - Sud America 86
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 9
OC - Oceania 3
Totale 2.775
Nazione #
US - Stati Uniti d'America 1.108
SG - Singapore 430
CN - Cina 310
TR - Turchia 279
IT - Italia 126
CA - Canada 105
BR - Brasile 78
UA - Ucraina 42
DE - Germania 34
GB - Regno Unito 28
HK - Hong Kong 28
PL - Polonia 15
IN - India 14
RU - Federazione Russa 14
NL - Olanda 13
EU - Europa 11
FR - Francia 11
JP - Giappone 11
MX - Messico 11
SE - Svezia 11
VN - Vietnam 11
IE - Irlanda 10
BD - Bangladesh 6
ES - Italia 6
FI - Finlandia 4
IQ - Iraq 4
KE - Kenya 4
SA - Arabia Saudita 4
CO - Colombia 3
ID - Indonesia 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
ZA - Sudafrica 2
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.775
Città #
Singapore 160
Santa Clara 153
San Mateo 147
Kocaeli 145
Dallas 136
Toronto 84
Ashburn 58
Houston 53
Rome 51
Shanghai 50
Chandler 44
Wilmington 41
Beijing 34
Guangzhou 28
Hong Kong 28
Lawrence 28
Princeton 28
West Jordan 28
Los Angeles 25
Warsaw 15
Boston 14
Seattle 14
Munich 13
São Paulo 13
Council Bluffs 12
Tokyo 11
Assago 10
Chicago 10
Fairfield 10
Shenzhen 10
Montreal 9
New York 9
Atlanta 8
Brooklyn 8
Milan 8
Stockholm 8
Wandsworth 8
Woodbridge 8
Buffalo 6
Cambridge 6
Mexico City 6
San Francisco 6
The Dalles 6
Wuhan 6
Boardman 5
Charlotte 5
Rui'an 5
Wuxi 5
Xi'an 5
Amsterdam 4
Chennai 4
Dublin 4
Frankfurt am Main 4
Hanoi 4
Manchester 4
Nairobi 4
Ottawa 4
Phoenix 4
Verona 4
Campinas 3
Cassino 3
Helsinki 3
Ho Chi Minh City 3
Jinhua 3
London 3
Medan 3
Nantong 3
Paris 3
Tashkent 3
Andover 2
Aversa 2
Belford Roxo 2
Cincinnati 2
Cisterna di Latina 2
Columbus 2
Denver 2
Florence 2
Fresno 2
Gatchina 2
Haining 2
Jeddah 2
Jiaxing 2
Johannesburg 2
Kuala Lumpur 2
Kyiv 2
Labarthe-sur-Lèze 2
Nanjing 2
New Delhi 2
New Taipei 2
Norfolk 2
Orsogna 2
Philadelphia 2
Pittsburgh 2
Poggibonsi 2
Poplar 2
Pune 2
Quanzhou 2
Queens 2
Ribeirão Preto 2
Rio de Janeiro 2
Totale 1.712
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 91
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY 59
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect 58
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 52
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. 50
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome 50
Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients 48
Cellular Models for Understanding Adipogenesis, Adipose Dysfunction, and Obesity 47
Endothelial effects of drugs designed to treat erectile dysfunction 45
Essential role of ICAM-1 in aldosterone-induced atherosclerosis 45
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction 44
Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor 43
Anticoagulation in "real world" patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study 42
Androgens and cardiovascular disease: gender-related differences 41
Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay 41
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice 40
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism 39
Vitamin D: a novel player in endothelial function and dysfunction 39
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? 39
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs 38
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro 38
On-target antihypertensive treatment in Italy: The ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study 38
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion 37
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? 37
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 36
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose 35
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT 29
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents 29
Trimetazidine improves exercise performance in patients with peripheral arterial disease 28
Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients 25
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 24
Ranolazine 23
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 23
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib 23
Effect of exercise training on serum capacity to induce endothelial cell death in patients with chronic heart failure 22
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 22
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. 22
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review 22
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology(ESC>) 22
Cardiac Metabolism in Myocardial Ischemia 21
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 20
Physical Training Reduces the Ability of Serum from Patients with Heart Failure to Induce Endothelial Cell Death 20
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance 20
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation 20
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 20
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure 20
Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. 19
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 19
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. 18
Effects of Nebivolol versus Carvedilol in Hypertensive Patients with Chronic Heart Failure 18
Intensive cardiac rehabilitation improves glucometabolic state of non-diabetic patients with recent coronary artery bypass grafting 18
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review- From the Optimal Nutraceutical Supplementation in Heart Failure (Onus-HF) Working Group. 18
Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. 18
Low testosterone levels are associated with coronary artery disease in male patients with angina. 17
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 17
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 17
Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77] 17
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients 17
Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment 17
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 17
COMPARISON BETWEEN INTERVAL TRAINING AND ENDURAND TRAINING ON 24-H BLOOD PRESSURE AND GLUCOSE METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILURE: A PILOT STUDY 17
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. 17
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 17
Validation of rate of perceived exertion-based exercise training in patients with heart failure: Insights from autonomic nervous system adaptations. 16
Immunoregulation through extracellular nucleotides 16
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice 16
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study. 16
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 16
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 16
Role of leucocyte count and thyroid-stimulating hormone in evolution of mild cognitive impairment to dementia 15
Clinical utility of ivabradine in cardiovascular disease management: current status 15
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes 15
Anabolic hormonal response to different exercise training intensities in men with chronic heart failure 15
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology and the the European Society of Hypertension 15
Menopause and cardiovascular disease: the evidence. Rosano GM, Vitale C, Marazzi G, Volterrani M 15
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology 15
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. 15
Mineralocorticoid receptor activation affects skeletal muscle development and metabolism. 15
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 15
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure 15
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 14
Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients. 14
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 14
Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. 14
Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease 14
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model. 14
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation 14
Metabolic management of diabetic patients with ischaemic heart disease 14
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 14
Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome 14
Testosterone and heart failure. 13
Estrogen acutely increases peripheral blood flow in postmenopausal women. 13
Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment 13
Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure. 13
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry 13
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine 13
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. 13
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study 13
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure 13
Comparison of Low-Dose Statin Versus Low-Dose Statin+Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial) 13
Totale 2.456
Categoria #
all - tutte 40.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 17 3 4 7 22 15 8 12 9 148 16
2021/2022288 1 82 83 8 0 0 18 28 5 58 2 3
2022/2023245 61 1 3 14 11 17 0 13 9 93 19 4
2023/2024343 4 0 10 32 9 14 1 22 4 59 14 174
2024/20251.247 93 287 50 30 49 174 57 68 187 17 58 177
2025/2026449 268 181 0 0 0 0 0 0 0 0 0 0
Totale 2.930